Avalyn Pharma
AVLN
25.53
+0.10
+0.39%
Avalyn Pharma
US · AVLN
#3161 by market cap
Listed 2026
25.53
+0.10
+0.39%
Live - 5344 symbols - heartbeat 276s ago
· 2026-10-08 04:12
Pre-market
25.98
+1.74%
After-hours
25.53
0.00%
- Market cap
- 1.13B
- P/E (TTM)i
- -10.96
- P/Bi
- 2.84
- EPSi
- -2.04
- Div yieldi
- 0.00%
- 52W posi
- 9%
Reader sentiment
Are you bullish or bearish on AVLN?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Jefferies Maintains Avalyn Pharma(AVLN.US) With Buy Rating, Maintains Target Price $52Market Newswire · 2026/8/13
-
Rating change
Morgan Stanley Maintains AVALYN PHARMA INC(AVLN.US) With Buy Rating, Maintains Target Price $53Market Newswire · 2026/6/4
-
Morgan Stanley Maintains Avalyn Pharma(AVLN.US) With Buy Rating, Raises Target Price to $57Market Newswire · 2026/8/13
-
Analysts Offer Insights on NA Companies: Avalyn Pharma Inc (AVLN) and EquipmentShare.com, Inc. (EQPT)TipRanks · 2026/8/13
-
Rating change
Analysts Are Bullish on These NA Stocks: MiniMed Group, Inc. (MMED), Avalyn Pharma Inc (AVLN)TipRanks · 2026/6/4
-
Raymond James Initiates Avalyn Pharma(AVLN.US) With Buy Rating, Announces Target Price $60Market Newswire · 2026/10/2
-
Rating change
Evercore Initiates AVALYN PHARMA INC(AVLN.US) With Buy Rating, Announces Target Price $51Market Newswire · 2026/5/26
-
Rating change
Jefferies Initiates AVALYN PHARMA INC(AVLN.US) With Buy Rating, Announces Target Price $52Market Newswire · 2026/5/25
-
Jefferies Maintains AVALYN PHARMA INC(AVLN.US) With Buy Rating, Maintains Target Price $52Market Newswire · 2026/5/26
-
Rating change
Morgan Stanley Initiates AVALYN PHARMA INC(AVLN.US) With Buy Rating, Announces Target Price $53Market Newswire · 2026/5/26
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 04:12:40 · For reference only, not investment advice and not tailored to your situation.